1.0FARMAPOL Sp. z o.o.https://farmapol.pl/en/ad_min_developerhttps://farmapol.pl/en/author/ad_min_developer/rich600338<blockquote class="wp-embedded-content" data-secret="tRcRoitRXJ"><a href="https://farmapol.pl/en/fundusze-unijne/">European Union Funds</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://farmapol.pl/en/fundusze-unijne/embed/#?secret=tRcRoitRXJ" width="600" height="338" title="“European Union Funds” — FARMAPOL Sp. z o.o." data-secret="tRcRoitRXJ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://farmapol.pl/wp-includes/js/wp-embed.min.js /* ]]> */ </script> Project “Research and development on new medicine Asmag B6 Forte” No RPWP.01.02.00-30-0012/19 implemented under the Regional Operational Programme of the Wielkopolska Region 2014-2020. Measure: 1.2. The strengthening of the innovative potential of the Wielkopolska Region enterprises. Beneficiary: ZAKŁAD CHEMICZNO – FARMACEUTYCZNY “FARMAPOL” SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ The aim of the project is to conduct research and development works in favour of the creation of Asmag B6 Forte medicine containing magnesium citrate and vitamin B6. As part of the project, development of laboratory infrastructure is planned for the purpose of R+D works. Total value of the project: PLN 931 400,00 Contribution of the EU: PLN 620 000,00 The project is being implemented in Poznań (ul. Św. Wojciech 29, 61-749 Poznań)    http://farmapol.pl/wp-content/uploads/2020/04/flaga-1024x107.jpg